Arrhythmia Management Devices

  title={Arrhythmia Management Devices},
  author={W. Frits Prinzen and Kevin Vernooy and Angelo Auricchio},
2407 More than 2 decades of research has established the role of cardiac resynchronization therapy (CRT) in medically refractory, mild to severe systolic heart failure (HF) with abnormal QRS duration and morphology. CRT confers a mortality benefit, reduces HF hospitalizations, and improves functional outcome in this population, but not all patients… CONTINUE READING